Beyond Weight Loss: 59 percent of GLP-1 Users Say the Prescription Drug Changed Their Dating Lives
Neuropeptides 71:7080 Zhang L, Zhang L, Li L, Holscher C (2019) Semaglutide is neuroprotective and reduces alpha-synuclein levels in the chronic MPTP mouse model of Parkinsons disease
In each tissue slide, three fields were evaluated
Benefit: Systemic Anti-Inflammatory Focus Area: Joints & Muscles Mechanism of Action: Lowers systemic inflammatory markers without the side effects of NSAIDs
Others can affect the efficacy of your medication or cause unnecessary discomfort
And it's just a really exciting time to be working in this area now that the treatments are potentially so much more impactful and can make so much of a difference, as witnessed by the results in this study. ONeil is a principal investigator on numerous corporately sponsored clinical trials involving potential obesity treatments, including Novo Nordisk